These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38035930)

  • 1. Corrigendum to "What and how can we learn from complex global problems for antimicrobial resistance policy? A comparative study combining historical and foresight approaches" [Journal of Global Antimicrobial Resistance 35 (2023) 110-121].
    Pitchforth E; Ali GC; Smith E; Taylor J; Rayner T; Lichten C; d'Angelo C; Gradmann C; Berridge V; Bertscher A; Allel K
    J Glob Antimicrob Resist; 2023 Dec; 35():357. PubMed ID: 38035930
    [No Abstract]   [Full Text] [Related]  

  • 2. What and how can we learn from complex global problems for antimicrobial resistance policy? A comparative study combining historical and foresight approaches.
    Pitchforth E; Gemma-Clare A; Smith E; Taylor J; Rayner T; Lichten C; d'Angelo C; Gradmann C; Berridge V; Bertscher A; Allel K
    J Glob Antimicrob Resist; 2023 Dec; 35():110-121. PubMed ID: 37714379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Molecular typing and antimicrobial resistance of group B Streptococcus clinical isolates in Saudi Arabia" [Journal of Global Antimicrobial Resistance 35 (2023) 244-251].
    Alzayer M; Alkhulaifi MM; Alyami A; Aldosary M; Alageel A; Garaween G; Shibl A; Al-Hamad AM; Doumith M
    J Glob Antimicrob Resist; 2024 Mar; 36():493. PubMed ID: 38521550
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis" [Journal of Global Antimicrobial Resistance 34 (2023) 30-38].
    Wang Y; Du J; Zhang D; Jin C; Chen J; Wang Z; Mei T; Fu K; Qian Q; Pang T
    J Glob Antimicrob Resist; 2023 Dec; 35():354. PubMed ID: 38035927
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Combined mutations of the penA with ftsX genes contribute to ceftriaxone resistance in Neisseria gonorrhoeae and peptide nucleic acids targeting these genes reverse ceftriaxone resistance" [Journal of Global Antimicrobial Resistance 35 (2023) 19-25].
    Zhu L; Liang J; Zheng Y; Cao W; Chen S; Xu Q; Yin S; Hong Y; Lai W; Gong Z
    J Glob Antimicrob Resist; 2023 Dec; 35():356. PubMed ID: 38035929
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to 'Fluoroquinolone sales in food animals and quinolone resistance in non-typhoidal Salmonella from retail meats: United States, 2009-2018' [Journal of Global Antimicrobial Resistance 29 (2022) 163-167].
    Yin X; Dudley EG; Pinto CN; M'ikanatha NM
    J Glob Antimicrob Resist; 2022 Sep; 30():489. PubMed ID: 36088081
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'Genome sequence of a multidrug-resistant Klebsiella pneumoniae ST78 with high colistin resistance isolated from a patient in India' [Journal of Global Antimicrobial Resistance 17 (2019) 187-188].
    Paul M; Narendrakumar L; Vasanthakumary AR; Joseph I; Thomas S
    J Glob Antimicrob Resist; 2022 Jun; 29():563. PubMed ID: 35717074
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to 'Insertion sequence mediating mgrB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China' [Journal of Global Antimicrobial Resistance 30 (2022) 357-362].
    Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
    J Glob Antimicrob Resist; 2023 Mar; 32():196. PubMed ID: 36935127
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "The fexA gene in Campylobacter: whether the spread has occurred among various hosts in eastern China" [Journal of Global Antimicrobial Resistance 36 (2024) 293-300].
    Huang P; Chen C; Zang X; Jiang Q; Lv Y; Lv H; Qin Y; Jiao X; Huang J
    J Glob Antimicrob Resist; 2024 Jun; 37():245. PubMed ID: 38897712
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing Enterobacterales' [Journal of Global Antimicrobial Resistance 35 (2023) 62-66].
    Papa-Ezdra R; Araújo L; Caiata L; Ferreira F; Ávila P; Seija V; Galiana A; Bado I; Vignoli R
    J Glob Antimicrob Resist; 2023 Dec; 35():355. PubMed ID: 38035928
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients" [Journal of Global Antimicrobial Resistance 35 (2023) 347-353].
    Qin Y; Jiao Z; Ye YR; Shen Y; Chen Z; Chen YT; Li XY; Lv QZ
    J Glob Antimicrob Resist; 2024 Mar; 36():492. PubMed ID: 38521549
    [No Abstract]   [Full Text] [Related]  

  • 12. Appraising research policy instrument mixes: a multicriteria mapping study in six European countries of diagnostic innovation to manage antimicrobial resistance.
    Coburn J; Bone F; Hopkins MM; Stirling A; Mestre-Ferrandiz J; Arapostathis S; Llewelyn MJ
    Res Policy; 2021 May; 50(4):104140. PubMed ID: 33941992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using strategic foresight to assess conservation opportunity.
    Cook CN; Wintle BC; Aldrich SC; Wintle BA
    Conserv Biol; 2014 Dec; 28(6):1474-83. PubMed ID: 25381735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to 'Prevalence of some virulence factors and genotyping of hospital-acquired uropathogenic Escherichia coli isolates recovered from cancer patients' [Journal of Global Antimicrobial Resistance 23 (2020) 211-216].
    Mahmoud AT; Ibrahem RA; Salim MT; Gabr A; Halby HM
    J Glob Antimicrob Resist; 2021 Sep; 26():344. PubMed ID: 34531037
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Antibiotic expectation, behaviour, and receipt among patients presenting to emergency departments with uncomplicated upper respiratory tract infection during the COVID-19 pandemic" [Journal of Global Antimicrobial Resistance 33 (2023) 89-96].
    Huang Z; Kuan WS; Tan HY; Seow E; Tiah L; Peng LL; Weng Y; Chow A
    J Glob Antimicrob Resist; 2023 Jun; 33():376. PubMed ID: 37331725
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'Draft genome sequence of a multidrug-resistant Pseudomonas aeruginosa producing blaSIM metallo-β-lactamase: London, UK' [Journal of Global Antimicrobial Resistance 29 (2022) 222-224].
    Bean DC; Wareham DW
    J Glob Antimicrob Resist; 2022 Sep; 30():490. PubMed ID: 36088082
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to 'Description of a new non-Tn4401 element (NTE
    Campana EH; Kraychete GB; Montezzi LF; Xavier DE; Picão RC
    J Glob Antimicrob Resist; 2023 Sep; 34():271. PubMed ID: 37689435
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to 'Draft genome sequence of a metallo-β lactamase (blaAIM-1)-producing Klebsiella pneumoniae ST1916 isolated from a patient with chronic diarrhoea' [Journal of Global Antimicrobial Resistance 16 (2019) 165-167].
    Zhou H; Guo W; Zhang J; Li Y; Zheng P; Zhang H
    J Glob Antimicrob Resist; 2021 Sep; 26():345. PubMed ID: 34531038
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to 'Clonal/subclonal changes and accumulation of CTX-M-type β-lactamase genes in fluoroquinolone-resistant Escherichia coli ST131 and ST1193 strains isolated during the past 12 years, Japan' [Journal of Global Antimicrobial Resistance 27 (2021) 150-155].
    Fukushima Y; Sato T; Tsukamoto N; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
    J Glob Antimicrob Resist; 2023 Mar; 32():195. PubMed ID: 36935126
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress Report: Antimicrobial Drug Discovery in the Resistance Era.
    Shinu P; Mouslem AKA; Nair AB; Venugopala KN; Attimarad M; Singh VA; Nagaraja S; Alotaibi G; Deb PK
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.